The potential negative impact of antibiotic pack on antibiotic stewardship in primary care in Switzerland: a modelling study. [PDF]
BACKGROUND: In Switzerland, oral antibiotics are dispensed in packs rather than by exact pill-count. We investigated whether available packs support compliance with recommended primary care treatment regimens for common infections in children and adults.
Berger, C +5 more
core +3 more sources
Reactive Infectious Mucocutaneous Eruption (RIME): An Australian Case Series
ABSTRACT Whilst Reactive Infectious Mucocutaneous Eruption (RIME) displays a low mortality rate, the condition results in significant morbidity and resource allocation, including prolonged hospital admission. As such, early diagnosis and optimisation of treatment is imperative.
Hamish Moore +2 more
wiley +1 more source
Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: a preliminary, intrahospital, controlled clinical trial [PDF]
Background: The aim of this study was to compare the days of hospitalization length between patients treated with Moxifloxacin with that of patients treated with a Clindamycin/Ceftriaxone combination and additionally, to isolate and identify the oral ...
Garrocho Rangel, Arturo +5 more
core +2 more sources
Abstract Purpose To evaluate the incidence, outcomes, and risk factors of numerical hypotony (NH) and choroidal effusion (CE) following standalone PRESERFLO MicroShunt (PMS) implantation. Methods Primary open‐angle glaucoma (POAG) and pseudoexfoliative glaucoma (PXG) patients with uni‐ or bilateral surgery at a tertiary university hospital were ...
Emil Nasyrov +5 more
wiley +1 more source
Comparison of the Efficacy of Moxifloxacin Preparations in the Therapy of Conjunctivitis
Purpose. To evaluate the efficacy and safety of therapy in patients with bacterial conjunctivitis using Moxioftan® eye drops, 5 mg/mL, 5 mL (JADRAN-GALENSKI LABORATORIJ, Croatia), and Vigamox® eye drops, 5 mg/mL, 5 mL (Alcon Laboratories, Inc., USA ...
A. Yu. Malygin +2 more
doaj +1 more source
Estudios de acoplamiento molecular de nuevos análogos de quinolonas a la ADN girasa de Escherichia coli [PDF]
Indexación: Scopus.Chemicals and CAS Registry Numbers: amino acid, 65072-01-7; ciprofloxacin, 85721-33-1; DNA topoisomerase (ATP hydrolysing); gatifloxacin, 112811-59-3, 180200-66-2; levofloxacin, 100986-85-4, 138199-71-0; lomefloxacin, 98079-51-7 ...
Davila, C. +3 more
core
Empirical treatment of bacterial keratitis: an international survey of corneal specialists. [PDF]
Background/aimsNew antibiotic agents and changing susceptibility patterns may have changed the empirical treatment of bacterial keratitis. Our objective in this study was to survey cornea specialists' practice patterns in the initial treatment of ...
Austin, Ariana +5 more
core +2 more sources
(1) Background: The World Health Organisation (WHO) categorises moxifloxacin and levofloxacin as Group A drugs, which should be prioritised in the treatment of rifampicin-resistant tuberculosis.
Stella M. Fabiane +6 more
doaj +1 more source
Temesgen Sidamo,1 Workineh Shibeshi,1 Getnet Yimer,2 Eleni Aklillu,3 Ephrem Engidawork1 1Department of Pharmacology & Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 2Global One Health ...
Sidamo T +4 more
doaj
'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.' [PDF]
BACKGROUND Differences in the determinants of Chlamydia trachomatis ('chlamydia') and Mycoplasma genitalium (MG) genital infection in women are not well understood.
Birden, Hudson +20 more
core +1 more source

